Gilbert M. Rishton
Amgen
One Amgen Center Drive
Thousand Oaks
California 91320-1789
USA
Name/email consistency: high
- Nonleadlikeness and leadlikeness in biochemical screening. Rishton, G.M. Drug Discov. Today (2003)
- Fenchylamine sulfonamide inhibitors of amyloid beta peptide production by the gamma-secretase proteolytic pathway: potential small-molecule therapeutic agents for the treatment of Alzheimer's disease. Rishton, G.M., Retz, D.M., Tempest, P.A., Novotny, J., Kahn, S., Treanor, J.J., Lile, J.D., Citron, M. J. Med. Chem. (2000)